{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:42:28Z","timestamp":1775277748804,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Western Regional Center for Excellence, USA","award":["U54 AI057156"],"award-info":[{"award-number":["U54 AI057156"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.09.021","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T21:47:15Z","timestamp":1348004835000},"page":"6777-6782","source":"Crossref","is-referenced-by-count":60,"title":["Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity"],"prefix":"10.1016","volume":"30","author":[{"given":"A.E.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Titball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.09.021_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00000441-200206000-00002","article-title":"Terrorism from a public health perspective","volume":"323","author":"Evans","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.09.021_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.1990.43.389","article-title":"Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB\/c mice","volume":"43","author":"Simpson","year":"1990","journal-title":"Am J Trop Med Hyg"},{"issue":"December (3\u20134)","key":"10.1016\/j.vaccine.2012.09.021_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.09.021_bib0025","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0030","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"49","key":"10.1016\/j.vaccine.2012.09.021_bib0035","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1016\/j.vaccine.2010.09.062","article-title":"Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)","volume":"28","author":"Fellows","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1155\/2012\/731604","article-title":"Advanced development of the rF1V and rBV A\/B vaccines: progress and challenges","volume":"2012","author":"Hart","year":"2012","journal-title":"Adv Prev Med"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.021_bib0045","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1208\/aapsj0902019","article-title":"Nanosystems for simultaneous imaging and drug delivery to T cells","volume":"9","author":"Fahmy","year":"2007","journal-title":"AAPS J"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nano.2008.06.002","article-title":"Emerging nanopharmaceuticals","volume":"4","author":"Bawarski","year":"2008","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0055","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/la9812828","article-title":"Synthesis and characterization of carboxylate-modified gold nanoparticle powders dispersible in water","volume":"15","author":"Chen","year":"1999","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.021_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02930965","article-title":"Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei","volume":"48","author":"Chen","year":"2003","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1039\/df9511100055","article-title":"A study of the nucleation and growth processes in the synthesis of colloidal gold","volume":"11","author":"Turkevich","year":"1951","journal-title":"Discuss Faraday Soc"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2012.09.021_bib0070","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","article-title":"Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells","volume":"6","author":"Chithrani","year":"2006","journal-title":"Nano Lett"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.09.021_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cyto.a.20846","article-title":"Nonendosomal cellular uptake of ligand-free, positively charged gold nanoparticles","volume":"77","author":"Taylor","year":"2010","journal-title":"Cytometry A"},{"issue":"7","key":"10.1016\/j.vaccine.2012.09.021_bib0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nmat2213","article-title":"Nanobiology: particles slip cell security","volume":"7","author":"Xia","year":"2008","journal-title":"Nat Mater"},{"issue":"8","key":"10.1016\/j.vaccine.2012.09.021_bib0085","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.09.021_bib0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.021_bib0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2006.05.022","article-title":"Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases","volume":"40","author":"Fuller","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.021_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/71889","article-title":"Synthetic DNA delivery systems","volume":"18","author":"Luo","year":"2000","journal-title":"Nat Biotech"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.09.021_bib0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity","volume":"21","author":"Miller","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0110","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response a microencapsulated sub-unit vaccine to for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0115","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1021\/la050588t","article-title":"Binding to citrate-coated gold nanoparticles and surfaces","volume":"21","author":"Brewer","year":"2005","journal-title":"Langmuir"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2012.09.021_bib0120","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague","volume":"29","author":"Williamson","year":"2011","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2012.09.021_bib0125","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1016\/j.vaccine.2011.06.119","article-title":"Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines","volume":"29","author":"Quenee","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.09.021_bib0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0264-410X(94)90092-2","article-title":"Biodegradable microspheres as controlled-release tetanus toxoid delivery systems","volume":"12","author":"Alonso","year":"1994","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2012.09.021_bib0135","doi-asserted-by":"crossref","DOI":"10.1023\/A:1018942118148","article-title":"Determinants of release rate of tetanus vaccine from polyester microspheres","volume":"10","author":"Alonso","year":"1993","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.vaccine.2012.09.021_bib0140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0264-410X(91)90295-H","article-title":"Controlled release microparticles for vaccine development","volume":"9","author":"O\u2019Hagan","year":"1991","journal-title":"Vaccine"},{"issue":"June (19)","key":"10.1016\/j.vaccine.2012.09.021_bib0145","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","article-title":"Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype","volume":"33","author":"Demento","year":"2012","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.09.021_bib0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2006.06.023","article-title":"PLA\/PLGA nanoparticles for sustained release of docetaxel","volume":"325","author":"Musumeci","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J Nanobiotechnol"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2012.09.021_bib0160","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/JVI.76.15.7832-7842.2002","article-title":"Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine","volume":"76","author":"Emeny","year":"2002","journal-title":"J Virol"},{"issue":"33\u201334","key":"10.1016\/j.vaccine.2012.09.021_bib0165","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","article-title":"Enhanced humoral and memory B cellular immunity using HPV16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only","volume":"24","author":"Giannini","year":"2006","journal-title":"Vaccine"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2012.09.021_bib0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2009.05.008","article-title":"Modulation of innate and adaptive immunity by biodegradable nanoparticles","volume":"125","author":"Uto","year":"2009","journal-title":"Immunol Lett"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.09.021_bib0175","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.4049\/jimmunol.178.5.2979","article-title":"Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity","volume":"178","author":"Uto","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0180","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.vaccine.2009.03.047","article-title":"Induction of humoral and enhanced cellular immune responses by novel core\u2013shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration","volume":"27","author":"Caputoa","year":"2009","journal-title":"Vaccine"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2012.09.021_bib0185","doi-asserted-by":"crossref","first-page":"195101","DOI":"10.1088\/0957-4484\/21\/19\/195101","article-title":"Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide","volume":"21","author":"Chen","year":"2010","journal-title":"Nanotechnology"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2012.09.021_bib0190","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2011.01.014","article-title":"Induction of humoral immune response against PfMSP-1(19) and PvMSP-1(19) using gold nanoparticles along with alum","volume":"29","author":"Parween","year":"2011","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2012.09.021_bib0195","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1016\/j.biomaterials.2011.07.009","article-title":"The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"issue":"July (10)","key":"10.1016\/j.vaccine.2012.09.021_bib0200","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2012.09.021_bib0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.021_bib0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"issue":"October","key":"10.1016\/j.vaccine.2012.09.021_bib0215","first-page":"9","article-title":"Liver uptake of gold nanoparticles after intraperitoneal administration in vivo: a fluorescence study","volume":"10","author":"Abdelhalim","year":"2011","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.021_bib0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jbm.a.20020","article-title":"Cytotoxicity evaluation of ceramic particles of different sizes and shapes","volume":"68A","author":"Yamamoto","year":"2003","journal-title":"J Biomed Mater Res, Part A"},{"key":"10.1016\/j.vaccine.2012.09.021_bib0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/smll.200400093","article-title":"Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity","volume":"1","author":"Connor","year":"2005","journal-title":"Small"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2012.09.021_bib0230","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbrc.2010.02.046","article-title":"Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice","volume":"393","author":"Lasagna-Reeves","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.vaccine.2012.09.021_bib0235","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.chembiol.2005.09.008","article-title":"Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death","volume":"12","author":"Lovric","year":"2005","journal-title":"Chem Biol"},{"issue":"October (3\u20134)","key":"10.1016\/j.vaccine.2012.09.021_bib0240","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.aquatox.2011.07.005","article-title":"Effects of Cu2O nanoparticle and CuCl2 on zebrafish larvae and a liver cell-line","volume":"105","author":"Chen","year":"2011","journal-title":"Aquat Toxicol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.09.021_bib0245","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/IAI.65.5.1926-1930.1997","article-title":"Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague","volume":"65","author":"Titball","year":"1997","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T14:44:02Z","timestamp":1714401842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":49,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0264410X1201331X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}